• BIRB 796 (Doramapimod) in p38α Research

  2026-08-12

  BIRB 796 (Doramapimod) combines strong p38α selectivity with an allosteric mechanism suited to inflammation, cytokine, and apoptosis workflows. This guide translates its molecular behavior into practical dosing, dephosphorylation, assay-control, and troubleshooting strategies.

• CHIR-99021 (CT99021) Stem Cell Workflow Guide

  2026-08-12

  Use CHIR-99021 (CT99021) as a timed GSK-3 perturbation rather than a one-size-fits-all additive for pluripotency, cardiac differentiation, and neuronal assays. This workflow connects Wnt/β-catenin pathway control with isoform-aware TRIM46 measurements to improve interpretation of axon-formation experiments.

• TAK1–YAP Control of Gastric Cancer Stem Cells

  2026-08-11

  The reference study identifies a mechanistic pathway in which IL-6-induced TAK1 stabilizes YAP and supports SOX2/SOX9-dependent self-renewal and oncogenesis of gastric cancer stem cells. Its combination of tissue profiling, functional perturbation, molecular interaction analysis, and in vivo validation provides a framework for studying how inflammatory signaling sustains therapy-relevant tumor cell populations.

• Proteinase K for DNA Workflows and Protease Assays

  2026-08-11

  Proteinase K combines broad protein hydrolysis with compatibility across detergents, chelators, and DNA-preserving workflows. This guide shows how to use it for genomic DNA isolation, enzyme contaminant removal, assay controls, and practical troubleshooting while applying lessons from a SARS-CoV-2 protease inhibitor study.

• Drug-Response Metrics in Cancer In Vitro

  2026-08-10

  Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell killing are related but non-equivalent components of an in vitro drug response. The framework supports more informative cancer drug assays by pairing endpoint measurements with attention to response magnitude and timing.

• Streptavidin-FITC in CRC Adhesion Assays

  2026-08-09

  Streptavidin-FITC provides a modular fluorescent route for measuring biotinylated bacteria, antibodies, and glycan probes in colorectal cancer adhesion studies. This article connects fluorescein isothiocyanate conjugated streptavidin with the ST3GAL1–sialylation mechanism underlying Fusobacterium nucleatum colonization, while emphasizing assay controls and interpretation.

• EZ Cap™ Firefly Luciferase mRNA Workflow

  2026-08-08

  Build sensitive cell-based translation, gene regulation, and delivery assays with Cap 1-capped firefly luciferase mRNA. Practical handling, formulation comparisons, and troubleshooting guidance help distinguish transcript stability, delivery efficiency, and biological signal loss.

• NHS-Biotin for Protein Labeling and Assays

  2026-08-07

  NHS-Biotin provides a practical route to stable amine-directed labeling for antibody detection, affinity purification, and intracellular protein studies. Its short spacer arm can complement emerging multimeric nanobody platforms by adding a compact streptavidin handle without introducing a large fusion tag.

• NHS-Biotin: Precision Protein Labeling for Multimeric Studie

  2026-08-07

  NHS-Biotin transforms protein engineering by enabling rapid, site-specific biotinylation for advanced detection, purification, and multimeric assembly workflows. This guide details experimental setups, optimization tactics, and troubleshooting strategies—backed by recent breakthroughs in nanobody multimerization—to help researchers maximize the reagent’s potential in both routine and cutting-edge applications.

• GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Inhibi

  2026-08-06

  The referenced study demonstrates that increasing GLT-1 expression in mice following traumatic brain injury (TBI) reduces neuronal apoptosis and cognitive dysfunction by suppressing the CB1-CREB signaling pathway. These findings clarify the mechanistic link between endocannabinoid signaling, astrocytic glutamate regulation, and neuroprotection in TBI, offering new molecular targets for therapeutic intervention.

• nor-Binaltorphimine dihydrochloride: Assay Reliability in KO

  2026-08-06

  This article provides laboratory-driven guidance on using nor-Binaltorphimine dihydrochloride (SKU B6269) to resolve common challenges in opioid receptor signaling research. Drawing on recent literature and practical assay scenarios, it demonstrates how this selective κ-opioid receptor antagonist ensures reproducibility, interpretability, and workflow efficiency for pain modulation studies.

• SHC-1 Inhibition Elevates CFTR Surface Abundance in Epitheli

  2026-08-05

  Barros et al. dissect the role of SHC-1 inhibition in modulating the plasma membrane abundance of the CFTR chloride channel across multiple epithelial cell models. Their findings clarify cell-type-specific mechanisms in CFTR trafficking, refining experimental approaches for cystic fibrosis and secretory diarrhea research.

• Structure-Based Inhibitor Screening of NSP15 in SARS-CoV-2

  2026-08-05

  This paper presents a structure-based virtual screening of natural compounds targeting NSP15, a SARS-CoV-2 endoribonuclease involved in immune evasion. Thymopentin and oleuropein were identified as potent inhibitors, with molecular dynamics confirming their stable binding, highlighting their potential for antiviral therapeutic development.

• Biotin-tyramide: Amplifying Signal Precision in IHC and ISH

  2026-08-04

  Biotin-tyramide stands out as a tyramide signal amplification reagent, enabling ultra-sensitive, HRP-catalyzed detection in tissue and cell assays. Its robust deposition efficiency, validated by APExBIO, drives high-resolution immunohistochemistry and in situ hybridization even when targets are low-abundance or spatially restricted.

• Itraconazole (SKU B2104): Reliable Solutions in Candida Rese

  2026-08-04

  This article addresses practical laboratory challenges in antifungal assays, highlighting how Itraconazole (SKU B2104) delivers reproducible, data-driven solutions for Candida research and drug interaction studies. Using scenario-based Q&A, it guides researchers on protocol optimization, data interpretation, and vendor reliability, emphasizing APExBIO's validated quality and tractable workflows.

8722 records 5/582 page Previous Next 12345 下5页 Last page